| URN | urn:agi-cas:58-64-0 |
|---|---|
| Total Entities | 3 |
| Connectivity | 2548 |
| Name | ADP |
| ChildConcepts | MgADP |
|---|---|
| thioGDP | |
| 8-bromo-ADP |
| Pathway | Actomyosin-Based Movement |
|---|---|
| Chronic Myeloid Leukemia Overview | |
| Young Onset PARK2, PINK1, and UCHL1 Induced Parkinson's Disease | |
| Glycolysis | |
| Insulin Influence on Lipogenesis | |
| Insulin Secretion | |
| Contraction due Vasospasm | |
| CFTR-Related Ion-Channel Dysfunction in Cystic Fibrosis Airway Epithelium (Class III Mutations) | |
| CFTR Up-regulates the Oxidative Stress in Airway Epithelium in Cystic Fibrosis | |
| CFTR Expression in Epithelial Cells (Class I Mutations) | |
| Airway Epithelial Cell Dysfunction in Cystic Fibrosis (Overview) | |
| Increased Uric Acid Synthesis in Gout | |
| Tricarboxylic acid cycle | |
| Glucose metabolism | |
| Glycogen metabolism | |
| Pentose-phosphate shunt | |
| Mannose metabolism | |
| Amino sugars synthesis | |
| Histidine metabolism | |
| Serine and Glycine metabolism | |
| Branched chain amino acids metabolism | |
| Ser/Gly/Thr/Cys metabolism | |
| Urea cycle and arginine metabolism | |
| Alanine metabolism | |
| Glu/Gln/Pro metabolsm | |
| Purine metabolism | |
| Pyrimidine metabolism | |
| Nicotinate and nicotinamide metabolism | |
| Folate biosynthesis | |
| Biosynthesis of cholesterol | |
| Metabolism of triacylglycerols | |
| Sphingolipid metabolism | |
| Fatty acid oxidation | |
| Respiratory chain and oxidative phosphorylation | |
| Metabolism of glycerophospholipids and ether lipids | |
| Fatty acid biosynthesis | |
| Galactose metabolism | |
| Ascorbate biosyntesis | |
| Pyruvate metabolism | |
| L-sugars oxidation | |
| Glutathione metabolism | |
| Malonate, propanoate and beta-alanine metabolism | |
| Riboflavin metabolism | |
| Vitamin B5 (pantothenate) metabolism and biosynthesis of CoA and holo-ACP | |
| Vitamin B6 (pyridoxine) metabolism | |
| Selencompound biosynthesis | |
| Vitamin B1(thiamine) metabolism | |
| Sulfur metabolism | |
| Glyoxylate and glycerate metabolism | |
| Mevalonate pathway | |
| Inositol phosphate metabolism | |
| Capecitabine and Fluorafur metabolism | |
| P2RY1/2/4/6 -> potassium channels | |
| P2RY2/12/13/14 -> N-type calcium channel | |
| P2RY11/13/14 -> IL8/10 production | |
| Glutamate release cycle | |
| GABA release cycle | |
| Summarized nociception-related expression targets | |
| Regulation of calcium flux | |
| fatty acid biosynthetic pathway | |
| adenosine monophosphate-activated protein kinase (AMPK) signaling pathway | |
| altered retinoid cycle metabolic pathway | |
| fatty acid biosynthetic pathway | |
| imtochondrial protein import pathway | |
| mitochondrial protein import pathway |
| Group | Biofluids assayable substances |
|---|
| Source | ChemIDplus |
|---|
| Alias | 2921-83-7 |
|---|---|
| sodium adenosine diphosphate | |
| 5'-Adenylphosphoric acid | |
| Adenosine 5'-diphosphoric acid | |
| Adenosindiphosphorsaeure | |
| Adenosine 5'-(trihydrogen diphosphate) | |
| Adenosine 5'-(trihydrogen diphosphate), disodium salt | |
| Adenosine 5'-(trihydrogen pyrophosphate) | |
| Adenosine 5'-diphosphate | |
| Adenosine 5'-diphosphorate | |
| 5'-ADP | |
| Adenosine 5'-pyrophosphate | |
| 2092-65-1 | |
| 58-64-0 | |
| 64142-77-4 | |
| 84412-16-8 | |
| disodium salt of Adenosine 5'-(trihydrogen diphosphate) | |
| 5' adenosine diphosphate | |
| adenosine diphosphate sodium | |
| adenosinediphosphoric acid | |
| adenylate phosphate | |
| levo adenosine diphosphate | |
| levo adp | |
| [alpha-17O]ADP | |
| 16178-48-6 | |
| Ado-5'-P-P | |
| 20398-34-9 | |
| 5'-Adenylphosphorate | |
| ADP | |
| Adenosine diphosphate | |
| Adenosine diphosphorate | |
| Adenosine diphosphoric acid | |
| Adenosine pyrophosphate | |
| Adenosine trisodium 5'-diphosphate trihydrate | |
| Adenosine, 5'-diphosphoric acid, disodium salt | |
| adenosine-5-diphosphate | |
| EINECS 240-314-7 | |
| ADP (nucleotide) | |
| Adenosine 5'-pyrophosphorate | |
| [3'-3H]ADP | |
| [2-3H]ADP | |
| Adenosine-5'-diphosphat | |
| [(3)H] ADP | |
| BRN 0067722 | |
| [(32)P]ADP | |
| adenosine-5'-diphosphoric acid (and/or unspecified salts) | |
| Adenosine 5'-pyrophosphoric acid | |
| Trisodium adenosinediphosphate trihydrate | |
| EINECS 218-249-0 | |
| EINECS 200-392-5 | |
| [14 C]ADP | |
| alpha-beta-methyleneadenosine 5'-diphosphate | |
| ADENOSINE, 5'-(TRIHYDROGEN PYROPHOSPHATE) | |
| Adenosine-5'-diphosphate | |
| CaADP | |
| AOPCP | |
| 4-adamantan-3-ylphenol | |
| 4-26-00-03629 (Beilstein Handbook Reference) |
| KEGG ID | C00008 |
|---|
| MedScan ID | 1206967 |
|---|
| HMDB ID | HMDB01341 |
|---|
| CAS ID | 58-64-0 |
|---|---|
| 84412-16-8 | |
| 896506-82-4 | |
| 905904-58-7 | |
| 16178-48-6 | |
| 2921-83-7 | |
| 2092-65-1 |
| PubChem SID | 134971804 |
|---|---|
| 135043217 | |
| 135232496 | |
| 148877 | |
| 662181 | |
| 3885245 |
| PubChem CID | 6022 |
|---|---|
| 85315 | |
| 197 |
| IUPAC Name | (5-adenin-9-yl-3,4-dihydroxy-tetrahydrofuran-2-yl)methyl phosphono hydrogen phosphate |
|---|---|
| [(2R,3S,4R,5R)-5-adenin-9-yl-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl phosphono hydrogen phosphate | |
| disodium;[[(2R,3S,4R,5R)-5-adenin-9-yl-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-oxido-phosphoryl] hydrogen phosphate | |
| disodium [[(2R,3S,4R,5R)-5-adenin-9-yl-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-oxido-phosphoryl] hydrogen phosphate |
| InChIKey | XTWYTFMLZFPYCI-UHFFFAOYSA-N |
|---|---|
| XTWYTFMLZFPYCI-KQYNXXCUSA-N | |
| ORKSTPSQHZNDSC-IDIVVRGQSA-L |
| Rotatable Bond Count | 6 |
|---|
| Molecular Weight | 427.201124 |
|---|---|
| 471.164783 | |
| 427.201122 | |
| 471.164782 |
| Molecular Formula | C10H15N5O10P2 |
|---|---|
| C10H13N5Na2O10P2 |
| XLogP | -4.600000 |
|---|---|
| -4.600000 | |
| -4.600000 | |
| -4.600000 |
| ChEBI ID | 16761 |
|---|
| Reaxys ID | 67722 |
|---|---|
| 968010 | |
| 1233930 | |
| 1233931 | |
| 1233932 | |
| 1233933 | |
| 1233934 | |
| 1233935 | |
| 5783046 | |
| 5783047 |
| LinkUrl | http://rgd.mcw.edu/rgdweb/ontology/annot.html?acc_id=CHEBI:16761&species=All |
|---|
| ChemIDplus ID | 000058640 |
|---|